about
Towards a unifying, systems biology understanding of large-scale cellular death and destruction caused by poorly liganded iron: Parkinson's, Huntington's, Alzheimer's, prions, bactericides, chemical toxicology and others as examplesNeuroprotective effect of nitric oxide donor isosorbide-dinitrate against oxidative stress induced by ethidium bromide in rat brainIron in multiple sclerosis: roles in neurodegeneration and repair.Importance of oligodendrocyte protection, BBB breakdown and inflammation for remyelination.The therapeutic effects of MSc1 nanocomplex, synthesized by nanochelating technology, on experimental autoimmune encephalomyelitic C57/BL6 miceBoosting endogenous neuroprotection in multiple sclerosis: the ASsociation of Inosine and Interferon beta in relapsing- remitting Multiple Sclerosis (ASIIMS) trial.Low dose dextromethorphan attenuates moderate experimental autoimmune encephalomyelitis by inhibiting NOX2 and reducing peripheral immune cells infiltration in the spinal cordSerum total antioxidant capacity in patients with multiple sclerosis.Assessment of the Relationship Between Red Cell Distribution Width and Multiple Sclerosis.Redox processes in neurodegenerative disease involving reactive oxygen speciesVitamin D3 attenuates oxidative stress and cognitive deficits in a model of toxic demyelinationEfficacy of fish oil on serum of TNF α , IL-1 β , and IL-6 oxidative stress markers in multiple sclerosis treated with interferon beta-1b.Prostaglandins in pathogenesis and treatment of multiple sclerosis.Immunopharmacological role of the leukotriene receptor antagonists and inhibitors of leukotrienes generating enzymes in multiple sclerosis.Regulatory T-cell as orchestra leader in immunosuppression process of multiple sclerosis.The role of reactive oxygen species and proinflammatory cytokines in type 1 diabetes pathogenesis.The potential role of iNKT cells in experimental allergic encephalitis and multiple sclerosis.The discovery and development of new potential antioxidant agents for the treatment of neurodegenerative diseases.Oxidative Stress and Neurobiology of Demyelination.Direct immunomodulatory influence of IFN-β on human astrocytoma cells.Modulating inflammation and neuroprotection in multiple sclerosis.beta-glucan from Saccharomyces cerevisiae as a blood platelet antioxidant.Alpha-lipoic acid mitigates toxic-induced demyelination in the corpus callosum by lessening of oxidative stress and stimulation of polydendrocytes proliferation.Low antioxidant status of serum uric acid, bilirubin and albumin in patients with neuromyelitis optica.
P2860
Q24289511-700AA649-FEA9-410D-93AF-12CF92263FE5Q28831295-DBD5CD90-4DCD-4BA7-B49C-59362015DE2EQ30835527-BE1BC9DB-C70E-4D47-BA83-DC4D02142794Q33740931-0BB124F7-B1C5-4933-A0CD-7E2ADA4E701CQ34065923-0EFE2FB3-4AF4-4159-82CD-7D00BA5BC723Q34101885-6A66B0BE-DAE9-4176-9821-3270C0361FFFQ35156771-761A1750-EB63-40ED-9CFA-E6121108FFF5Q35184699-F8400B32-0677-4D40-8744-5FF894C0EAB3Q36153528-9D14D9AC-BF56-4F59-8F9D-D6AD5372BCD3Q36460613-6FD47ED6-5D05-4F93-B850-C2B112BE9A46Q36773824-8D45B201-E812-40E4-B656-C09D338439EAQ36989834-40AA512E-C19C-4F9C-BB32-9F2D3C82B3CFQ37710103-C3627B40-A759-4CB6-A743-354A5B8649A7Q37713745-72B9485C-3BA3-4DEC-BF4A-011C47B2FDF6Q37834024-A5A9631C-985D-40B5-B1FB-8A7516D6D35FQ38074472-65D3E53B-7B47-4100-860E-6421B31BC4B6Q38193865-059E789D-AF0A-4617-96E0-6414CBB66BEAQ38233270-C925FBDF-1623-4669-8811-36FB14D267F7Q38287176-62D66E30-8166-40D9-8BB2-D7FA7AA552D5Q38908710-8D7FDCB7-6D83-4340-8FE9-86297779ACF4Q39350409-EC64DACE-04A3-4085-9073-3AEE0599D66FQ43072124-056F2724-EB9F-4B6F-9526-91889B7EABA8Q46288556-2FAD4574-F37F-4D48-8902-D9679C11CC88Q51432839-D856DD65-D315-4B9A-AA1D-63F76528746D
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Antioxidant therapy in multiple sclerosis.
@en
Antioxidant therapy in multiple sclerosis.
@nl
type
label
Antioxidant therapy in multiple sclerosis.
@en
Antioxidant therapy in multiple sclerosis.
@nl
prefLabel
Antioxidant therapy in multiple sclerosis.
@en
Antioxidant therapy in multiple sclerosis.
@nl
P2860
P1476
Antioxidant therapy in multiple sclerosis
@en
P2093
Monireh Mohsenzadegan
P2860
P356
10.1080/08923970802331943
P577
2009-01-01T00:00:00Z